STOCKWATCH
·
Pharmaceuticals
Quarterly Result17 Oct 2025, 12:27 pm

Acutaas Chemicals Q2 FY26 Revenue from Operations at Rs. 3,062 mn, up 24.1% YoY

AI Summary

Acutaas Chemicals Limited, a leading global manufacturer of advance pharmaceutical intermediates and speciality chemicals, has reported financial results for the quarter and half year ended September 30, 2025. The company's revenue from operations for Q2FY26 grew by 24.1% YoY to Rs. 3,062 mn. The gross margin for the quarter improved to 55.8% up 1,232 bps YoY. EBITDA for the quarter came at Rs. 953 mn up 94.8% YoY. EBITDA margin for the quarter was at 31.1% as compared to 19.8% in Q2FY25. PAT for the quarter was Rs. 719 mn up 91.3% as compared to PAT of Rs. 376 mn in Q2FY25. The PAT margin for the quarter was at 23.5% up 824 bps YoY. Export for the quarter at 76%; domestic business at 24%.

Key Highlights

  • Revenue from operations for Q2FY26 grew by 24.1% YoY to Rs. 3,062 mn
  • Gross margin for the quarter improved to 55.8% up 1,232 bps YoY
  • EBITDA for the quarter came at Rs. 953 mn up 94.8% YoY
  • EBITDA margin for the quarter was at 31.1% as compared to 19.8% in Q2FY25
  • PAT for the quarter was Rs. 719 mn up 91.3% as compared to PAT of Rs. 376 mn in Q2FY25
  • The PAT margin for the quarter was at 23.5% up 824 bps YoY
  • Export for the quarter at 76%; domestic business at 24%
AMIORG
Pharmaceuticals
Ami Organics Ltd

Price Impact